VHL vitasora health limited

stimuvax is out

  1. 520 Posts.
    http://cancerology.blogspot.com/2010/03/stimuvax-is-out.html

    Competitors

    Two other companies are developing therapeutic lung cancer vaccines. London-based drugmaker GlaxoSmithKline Plc began a final trial of its MAGE-A3 vaccine for lung cancer in 2007.

    Transgene SA, the French biotechnology firm backed by the billionaire Merieux family, plans to begin a final test of its TG4010 vaccine this year. The shot, like Stimuvax, targets cancers that express the mucin 1 tumor antigen. Swiss drugmaker Novartis last month bought an option on rights to the experimental vaccine in a deal that may fetch Transgene as much as $960 million.

    Transgene dropped 4.4 percent to 17.40 euros in Paris. The company is seeking to raise 150 million euros from investors, according to a report today in France?s Les Echos newspaper.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.6¢
Change
0.000(0.00%)
Mkt cap ! $44.68M
Open High Low Value Volume
2.6¢ 2.6¢ 2.6¢ $143.8K 5.533M

Buyers (Bids)

No. Vol. Price($)
1 68000 2.5¢
 

Sellers (Offers)

Price($) Vol. No.
2.7¢ 220386 3
View Market Depth
Last trade - 14.06pm 13/08/2025 (20 minute delay) ?
VHL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.